ElevateBio has announced plans to create and build a broad portfolio of single and multi-product cell and gene therapy companies. Leveraging the roughly $150 million it has raised to date, Elevate Bio plans to provide centralized bench-to-bedside capabilities including world-class scientists, manufacturing facilities, drug development and commercialization expertise. All of which will be housed in a new 100,000 sq. ft. R&D and Manufacturing center in Waltham, Massachusetts to be known as BaseCamp which is on schedule to be fully operational in Q3/Q4 of 2020.  In the meantime, the company is leveraging its lab space in Cambridge, Massachusetts to launch collaborations. Learn More